Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.77765 | 33 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.75828 | 33 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.77602 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.69436 | 33 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.9921 | 45 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.81196 | 32 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.7526 | 31 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.72919 | 33 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.74439 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.74007 | 33 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.74519 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.74765 | 34 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.74687 | 33 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.74906 | 33 |